Cross-Sectional Observational Study On Severe Asthmatics Under Treatment With Omalizumab In Italy

被引:0
|
作者
Novelli, F. [1 ]
Vergura, L. [1 ]
Latorre, M. [1 ]
Paggiaro, P. [1 ]
机构
[1] Univ Pisa, Pisa, Italy
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1298
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy
    Novelli, Federica
    Latorre, Manuela
    Vergura, Letizia
    Caiaffa, Maria Filomena
    Camiciottoli, Gianna
    Guarnieri, Gabriella
    Matucci, Andrea
    Macchia, Luigi
    Vianello, Andrea
    Vultaggio, Alessandra
    Celi, Alessandro
    Cazzola, Mario
    Paggiaro, Pierluigi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 31 : 123 - 129
  • [2] Laryngeal Dysfunction in Severe Asthma: A Cross-Sectional Observational Study
    Vertigan, Anne E.
    Kapela, Sarah L.
    Gibson, Peter G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (02): : 897 - 905
  • [3] Omalizumab treatment and exercise capacity in severe asthmatics - Results from a pilot study
    Schaeper, Christoph
    Glaeser, Sven
    Felix, Stephan B.
    Gogolka, Annette
    Koch, Beate
    Kruell, Matthias
    Ewert, Ralf
    Noga, Oliver
    RESPIRATORY MEDICINE, 2011, 105 (01) : 3 - 7
  • [4] Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
    Magnoni, Maria Sandra
    Latorre, Manuela
    Bettoncelli, Germano
    Guadalupe Sanchez-Herrero, M.
    Lopez, Araceli
    Calvo, Eduardo
    Rizzi, Andrea
    Caminati, Marco
    Senna, Gianenrico
    Paggiaro, Pierluigi
    WORLD ALLERGY ORGANIZATION JOURNAL, 2017, 10
  • [5] Nursing staffing and skill mix in nursing homes in Italy: An observational cross-sectional study
    Marchetti, Daniele
    Cosmai, Simone
    Xausa, Pietro
    Galbiati, Giancarlo
    Poliani, Andrea
    Mainardi, Chiara
    Mancin, Stefano
    Solitro, Gianluca
    GERIATRIC NURSING, 2025, 62 : 48 - 53
  • [6] Levels of Physical Activity in Spanish Asthmatics: A Cross-Sectional Study
    Castillo, Sheila Sanchez
    Smith, Lee
    Suarez, Arturo Diaz
    Sanchez, Guillermo Felipe Lopez
    MEDICINA-LITHUANIA, 2020, 56 (12): : 1 - 11
  • [7] Discontinuation rates of omalizumab treatment in a cohort of severe asthmatics in Bulgaria
    Hristova, Diana
    Kralimarkova, Tanya
    Popov, Todor A.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Infantile Hemangioma: A Cross-Sectional Observational Study
    Sandru, Florica
    Turenschi, Alina
    Constantin, Andreea Teodora
    Dinulescu, Alexandru
    Radu, Andreea-Maria
    Rosca, Ioana
    LIFE-BASEL, 2023, 13 (09):
  • [9] Effects of seven years treatment with omalizumab in severe uncontrolled asthmatics
    Pace, E.
    Ferraro, M.
    Chiappara, G.
    Bruno, A.
    Bousquet, J.
    Gjomarkaj, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [10] Asthma control is reached in a large majority of severe asthmatics treated with omalizumab. An Italian observational study
    Novelli, F.
    Lenzini, G.
    Latorre, M.
    Paggiaro, P.
    ALLERGY, 2013, 68 : 375 - 375